Collection of Blood, Urine, and Skin Samples for Research in Cutaneous T-cell Lymphoma, Eczema, and Atopic Dermatitis

What this Trial Is About

Researchers are conducting an observational study to collect tissue, urine, and blood samples from patients with cutaneous T-cell lymphoma CTCL, eczema, and atopic dermatitis. The study aims to support current and future research by providing a central system to monitor access to these biological specimens and to facilitate studies related to immunologic assays, tumor progression, genomic and proteomic analyses, and other research advancing CTCL treatment. Participants with CTCL, Sezary syndrome, atopic dermatitis, or eczema may provide samples including up to nine blood draws per year of 60 ml each and up to four 6 mm skin punch biopsies annually. Urine samples may also be collected as part of the study. These activities help gather important biological material for ongoing and future research projects. During the study, participants will be involved in sample collection procedures such as blood draws, skin biopsies, and urine collection. Researchers will use these samples to study proteomics and other biological markers related to the conditions. The study is ongoing with monitoring to support advancements in understanding and treating CTCL and related skin conditions. Participation involves consenting to provide these specimens and may continue over multiple years as needed for research purposes.

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research